Exploratory trials of complex public health interventions: development of guidance for researchers and funders

复杂公共卫生干预措施的探索性试验:为研究人员和资助者制定指南

基本信息

  • 批准号:
    MR/N015843/1
  • 负责人:
  • 金额:
    $ 31.15万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2016
  • 资助国家:
    英国
  • 起止时间:
    2016 至 无数据
  • 项目状态:
    已结题

项目摘要

Recognition is growing of the potential public health value of interventions to improve health behaviours such as diet, physical activity and substance use. Given the complex causality of these behaviours, improving public health often requires complex interventions which comprise multiple components interacting to produce change, with their actions constrained and facilitated by their interaction with the settings into which they are introduced. Given the cost of such interventions and the potential for unintended harms, drawing on evidence of what works and rigorously evaluating effectiveness is crucial.Where feasible, randomised controlled trials (RCTs) represent the most robust means of examining effectiveness. However, complex interventions are often difficult to implement in a manner consistent with programme theory across multiple settings and target groups, whilst conducting and interpreting RCTs in real word settings is challenging. Hence, prior to committing to definitive evaluation, randomised or otherwise, attention is needed to establishing the feasibility and acceptability of intervention plans and intended evaluation designs.The need to carefully examine these issues is increasingly recognised, with an increasing number of studies describing an objective of establishing the feasibility of full scale trials. Such studies are described under terms including 'exploratory trials', 'phase 2 trials' or 'piloting and feasibility' studies. However, there is currently a lack of consistent guidance for researchers preparing bids for such work, or for peer reviewers or funders, on the most important questions to address in such studies, key methodological considerations in addressing these questions, when it is more or less appropriate to use randomisation during this phase, and the criteria on which decisions should be made regarding whether and how to progress to a full scale definitive evaluation. Hence, as reflected by the range of terms under which such studies are described, their conduct and reporting is inconsistent, and the basis on which conclusions regarding whether or not to progress to a full-scale evaluation are made often unclear.The proposed study will develop guidance for the conduct of exploratory trials through reviewing current practice and eliciting views of expert funders and researchers, beginning by using systematic review methodology to identify studies describing an intention to investigate the potential for a full scale trial (including phase 2 trials, exploratory trials or feasibility and pilot studies) and existing guidance on their conduct. We will also conduct a horizon-scanning exercise to identify recent methodological developments in the design of phase 2 trials and pilot and feasibility studies in other areas of clinical research, to ensure that the guidance learns from recent developments in these related areas.A web-based Delphi process and consensus meeting will then be used to develop guidance on when exploratory trials should be conducted, what research questions they should address, key methodological considerations in the conduct of such studies and the range of criteria that should inform a decision to proceed to a full scale definitive trial. The guidance will then be actively disseminated to research funders, researchers and journal editors to maximise its impact on the commissioning, conduct and reporting of exploratory trials of complex public health interventions.
人们日益认识到改善饮食、身体活动和药物使用等健康行为的干预措施的潜在公共卫生价值。鉴于这些行为的复杂因果关系,改善公共卫生往往需要复杂的干预措施,这些干预措施包括相互作用以产生变化的多个组成部分,其行动受到它们与引入它们的环境的相互作用的制约和促进。考虑到此类干预措施的成本和潜在的意外危害,收集有效措施的证据并严格评估有效性至关重要。在可行的情况下,随机对照试验(RCTs)是检验有效性的最可靠的方法。然而,复杂的干预措施往往难以在多种环境和目标群体中以与项目理论一致的方式实施,而在现实世界环境中进行和解释随机对照试验是具有挑战性的。因此,在进行最终评估(随机或非随机)之前,需要注意确定干预计划和预期评估设计的可行性和可接受性。随着越来越多的研究描述了建立全面试验可行性的目标,人们越来越认识到需要仔细检查这些问题。这些研究被描述为“探索性试验”、“第二阶段试验”或“试点和可行性”研究。然而,对于准备投标这类工作的研究人员、同行评审人员或资助者,目前缺乏一致的指导,包括在这类研究中需要解决的最重要问题、解决这些问题时的关键方法学考虑、在这一阶段使用随机化是否合适以及如何进行全面确定评估的决策标准。因此,正如描述这些研究所用的各种术语所反映的那样,它们的行为和报告是不一致的,关于是否进展到全面评价的结论所依据的基础往往不明确。拟议的研究将通过审查目前的实践和征求专家资助者和研究人员的意见,为探索性试验的开展制定指导方针,首先使用系统的审查方法来确定那些描述了调查全面试验潜力的意图的研究(包括2期试验、探索性试验或可行性和试点研究),以及对其开展的现有指导。我们还将开展一项横向扫描工作,以确定第二阶段试验设计的最新方法学发展,以及其他临床研究领域的试点和可行性研究,以确保指南借鉴这些相关领域的最新发展。然后,基于网络的德尔菲过程和共识会议将用于制定指导意见,包括何时进行探索性试验,应解决哪些研究问题,进行此类研究时的关键方法学考虑因素,以及应决定进行全面确定试验的标准范围。然后,该指南将积极传播给研究资助者、研究人员和期刊编辑,以最大限度地影响复杂公共卫生干预措施探索性试验的委托、实施和报告。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Exploratory studies to decide whether and how to proceed with full-scale evaluations of public health interventions: a systematic review of guidance.
  • DOI:
    10.1186/s40814-018-0290-8
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    1.7
  • 作者:
    Hallingberg B;Turley R;Segrott J;Wight D;Craig P;Moore L;Murphy S;Robling M;Simpson SA;Moore G
  • 通讯作者:
    Moore G
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laurence Moore其他文献

Changes from 1986 to 2006 in reasons for liking leisure‐time physical activity among adolescents
1986年至2006年青少年喜欢休闲体育活动的原因变化
  • DOI:
    10.1111/sms.12528
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Bente Wold;Hannah Littlecott;J. Tynjälä;O. Samdal;Laurence Moore;C. Roberts;Lasse Kannas;J. Villberg;L. Aarø;L. Aarø
  • 通讯作者:
    L. Aarø
Development of a scale to measure 9–11-year-olds' attitudes towards breakfast
制定衡量 9-11 岁儿童对早餐态度的量表
  • DOI:
    10.1038/sj.ejcn.1602735
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    Katy Tapper;Simon Murphy;Rebecca Lynch;Rachel Clark;Graham Moore;Laurence Moore
  • 通讯作者:
    Laurence Moore
Mortality at ages 50–59 and deprivation at early and late stages of the life course in Wales
威尔士 50-59 岁死亡率以及生命历程早期和晚期阶段的贫困
BMC Family Practice
BMC 家庭诊所
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sharon Simpson;Anne;C. Butler;Hood Kerenza Cohen David Collett;Dunstan David;Evans Meirion John;Rhys;Rollnick;Moore Stephen;Monika Bekkers Laurence Anthony Russell Hare;Marie Evans;Kerry Hood;David Cohen;Frank Dunstan;Meirion R Evans;Stephen Rollnick;Laurence Moore;Monika Hare;Marie;John Evans
  • 通讯作者:
    John Evans
An exploratory cluster randomised trial of a university halls of residence based social norms intervention in Wales, UK
  • DOI:
    10.1186/1471-2458-12-186
  • 发表时间:
    2012-03-13
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Simon Murphy;Graham Moore;Annie Williams;Laurence Moore
  • 通讯作者:
    Laurence Moore

Laurence Moore的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laurence Moore', 18)}}的其他基金

Expansion of SPHSU Schools Health Research Networks
扩大 SPHSU 学校健康研究网络
  • 批准号:
    MC_PC_20040
  • 财政年份:
    2021
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
SPHSU/MRC EU - Participatory Systems Mapping
SPHSU/MRC EU - 参与式系统映射
  • 批准号:
    MC_PC_20039
  • 财政年份:
    2021
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
Future updates & dissemination of MRC Complex Intervention Guidance
未来更新
  • 批准号:
    MC_PC_20041
  • 财政年份:
    2021
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
Complexity in Health
健康的复杂性
  • 批准号:
    MC_UU_00022/1
  • 财政年份:
    2020
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
PHASE: The Population Health Agent based Simulation nEtwork
阶段:基于人口健康代理的模拟网络
  • 批准号:
    MR/S037594/1
  • 财政年份:
    2019
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Research Grant
Complexity in Health Improvement
健康改善的复杂性
  • 批准号:
    MC_UU_12017/14
  • 财政年份:
    2015
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
DECIPHer: Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement
DECIPher:改善公共卫生复杂干预措施的开发和评估中心
  • 批准号:
    MR/K023233/1
  • 财政年份:
    2014
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Research Grant
The rigorous development, implementation, and evaluation of the effectiveness and cost effectiveness of community-based interventions and policies, especially in relation to inequalities in health.The facilitation of two-way knowledge flows between r
严格制定、实施和评估基于社区的干预措施和政策的有效性和成本效益,特别是与健康不平等相关的干预措施和政策。促进不同群体之间的双向知识流动
  • 批准号:
    MC_PC_13027
  • 财政年份:
    2013
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Intramural
Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer)
公共卫生改善复杂干预措施开发和评估中心 (DECIPHer)
  • 批准号:
    ES/G007543/1
  • 财政年份:
    2009
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Research Grant
Free School Breakfast Initiative Data Augmentation and Analysis
免费学校早餐计划数据增强和分析
  • 批准号:
    G0701875/1
  • 财政年份:
    2009
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Research Grant

相似国自然基金

“智三针” 电针改善阿尔茨海默病认知碍的临床疗效评估:系列多交叉 “N-of-l trials研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
  • 批准号:
    10752555
  • 财政年份:
    2024
  • 资助金额:
    $ 31.15万
  • 项目类别:
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
  • 批准号:
    10481965
  • 财政年份:
    2024
  • 资助金额:
    $ 31.15万
  • 项目类别:
CAREER: Complex Causal Moderated Mediation Analysis in Multisite Randomized Trials: Uncovering the Black Box Underlying the Impact of Educational Interventions on Math Performance
职业:多地点随机试验中的复杂因果调节中介分析:揭示教育干预对数学成绩影响的黑匣子
  • 批准号:
    2337612
  • 财政年份:
    2024
  • 资助金额:
    $ 31.15万
  • 项目类别:
    Continuing Grant
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
  • 批准号:
    10751263
  • 财政年份:
    2024
  • 资助金额:
    $ 31.15万
  • 项目类别:
Core B: Clinical Trials Core
核心 B:临床试验核心
  • 批准号:
    10554476
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
  • 批准号:
    10367805
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
  • 批准号:
    10639471
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
Identifying and modeling immune correlates of protection against congenital CMV transmission after primary maternal infection
原发性母体感染后预防先天性巨细胞病毒传播的免疫相关性的识别和建模
  • 批准号:
    10677439
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice
表征下一代免疫人源化小鼠对 HIV-1 疫苗接种的抗体反应
  • 批准号:
    10673292
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 31.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了